Increased plasma concentrations of total homocysteine (tHcy; mild-moderate hyperhomocysteinemia: 15-50 μ tHcy) are considered an independent risk factor for the onset/progression of various diseases, but it is not known about how the increase in tHcy causes pathological conditions. Reduced homocysteine (HSH ∼1% of tHcy) is presumed to be toxic, unlike homocystine (∼9%) and mixed disulfide between homocysteine and albumin (HSS-ALB; homocysteine [Hcy]-albumin mixed disulfide, ∼90%). This and other notions make it difficult to explain the pathogenicity of Hcy because: (i) lowering tHcy does not improve pathological outcomes; (ii) damage due to HSH usually emerges at supraphysiological doses; and (iii) it is not known why tiny increments in plasma concentrations of HSH can be pathological.
View Article and Find Full Text PDFWith the increased use of reclaimed asphalt (RA), the ability of bituminous materials to resist fatigue cracking may face a decline mainly due to the aged reclaimed asphalt binder (RAB), especially when RA is used at higher rates and not sufficiently treated. In this study, the bulk scale (asphalt) and its subscale (mortar) were employed to evaluate the effect on fatigue resistance when a RAB is added, by considering three replacement rates: 0%, 40%, and 70% RAB. The fatigue testing of asphalt mixtures was carried out using a four-point bending (4PB) setup, while the mortars were tested using a new column-like geometry utilising a dynamic shear rheometer (DSR).
View Article and Find Full Text PDF